Skip to main content
Clinical Trials/NCT01130714
NCT01130714
Completed
N/A

Effectiveness of a Resistance Training Program on Inflammatory Markers and Chemotherapy Completion in Lung Cancer Patients on Chemotherapy

East Carolina University1 site in 1 country15 target enrollmentJanuary 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Inflammation
Sponsor
East Carolina University
Enrollment
15
Locations
1
Primary Endpoint
Systemic inflammation measured by c-reactive protein.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to examine the effectiveness of a resistance training program on reducing systemic inflammation and improving chemotherapy completion in lung cancer patients being treated with curative intent chemotherapy.

Registry
clinicaltrials.gov
Start Date
January 2010
End Date
July 2012
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kristina Karvinen

Assistant Professor

East Carolina University

Eligibility Criteria

Inclusion Criteria

  • Histologically diagnosed with lung cancer
  • Stage I, II, or III
  • Eligible for chemotherapy with curative intent
  • 21 years of age or older
  • Approval to participate in study by treating oncologist or family physician

Exclusion Criteria

  • Unstable cardiac disease
  • Untreated bone or brain metastases

Outcomes

Primary Outcomes

Systemic inflammation measured by c-reactive protein.

Time Frame: 12 weeks

Secondary Outcomes

  • Chemotherapy completion(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials